Marlon Braumann

Marlon Braumann was the founder of Ames Foundation (2020), store2be GmbH (2015), and Elevat3 Capital Ltd. (2020) where he holds the titles of Managing Director and Managing Partner respectively.
Dr. Braumann is also the founder of Amyriad Therapeutics, Inc. Dr. Braumann's current jobs include being a Director at Gropyus AG since 2021 and a Board Member at Bullfinch Holding GmbH since 2021.
Dr. Braumann's former job was as a Member-Supervisory Board at SynBiotic SE from 2020 to 2023.
Dr. Braumann's education includes an undergraduate degree from WHU-Otto Beisheim School of Management (2011), a graduate degree from WHU-Otto Beisheim School of Management (2013), a doctorate degree from WHU-Otto Beisheim School of Management (2015), an undergraduate degree from University Carlos III of Madrid (2014), and an MBA degree from Robert H.
Smith School of Business (2013).